Clinical Trial Update: Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer

View source ↗

Summary

Clinical trial exploring an exosome-based recurrence score for post-treatment ovarian cancer; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Fudan University | Conditions: Ovarian Cancer | Status: NOT_YET_RECRUITING